Loading…
EndoArt, a subsidiary of BSS pharmaceutical holding, is launching a plant in St. Petersburg for cemented and cementless hip endoprostheses. The project required 1 billion rubles in investment, with capacity for up to 35,000 units annually. The plant is set to launch in August 2024.